The leishmaniasis parasites are obligate intracellular protozoans which cause human cutaneous, mucocutaneous, or visceral leishmaniasis. In Tunisia and other North African countries, several forms of leishmaniasis coexist. Human cutaneous leishmaniasis (HCL) is caused by Leishmania major, Leishmania tropica, as well as a variant of Leishmania infantum (3). In opposition to HCL, Mediterranean visceral leishmaniasis (MVL), which is caused by Leishmania donovani infantum, is a severe and potentially lethal disease which needs a rapid and accurate diagnosis. The definitive diagnosis of leishmaniasis relies mainly on the demonstration of the presence of the parasite in a tissue sample and/or its isolation by culture as well as the detection by serological tests of specific antibodies to leishmanial antigens. The different methods of detection include indirect immunofluorescence (25) , enzyme-linked immunosorbent assays (ELISAs) with whole parasites, crude extracts, and purified or recombinant antigens (2, 7, 13, 18) , direct agglutination (14) , or immunoblot analysis (4, 5, 11, 17, 26, 27) . Some of these techniques suffer from a relative lack of specificity because of antigenic relatedness between Leishmania species and other microorganisms such as Trypanosoma cruzi, Echinococcus granulosus, Toxoplasma gondii, and the mycobacteria (4, 8, 26) . In countries where such pathogens coexist with leishmanias, the results of serological tests may be difficult to interpret, since the different Leishmania species involved in the various clinical forms of the disease may share cross-reactive antigens. Hence, in areas where both zoonotic cutaneous and visceral leishmaniases are endemic, a positive ELISA result could be due to an infection with either L. major or L. donovani infantum. The molecular basis of the crossreactivity is not fully defined. Immunoblotting techniques have been used to define both species-specific and cross-reactive leishmania antigens (22, 26 (vi) Group VI. Thirty-five control serum specimens were obtained from healthy Tunisian children (age range, 3 to 10 years).
(vii) Group VII. Forty control serum specimens were obtained from adult Tunisian patients suffering from various diseases such as systemic lupus erythematosus (n = 10), toxoplasmosis (n = 10), hydatidosis (n = 10), and tuberculosis (n = 10).
( (10) .
Soluble leishmania antigens (SLAs) were prepared from L. donovani infantum promastigotes as described by Melby et al. (24) . The protein concentration was determinated by the protein assay described by Lowry et al. (23) .
SDS-PAGE and immunoblotting. Sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) was carried out in a 7 to 17% gradient gel with a 1% stacking gel as described by Laemmli (20 major reactive antigens were Gp63 (n = 18; 90%) and the low-molecular-mass antigens (10 to 20 kDa) (n = 19; 95%). However, the 32-kDa polypeptide of L. donovani infantum membranes revealed by the sera from patients with HVL was found to be constantly unreactive (Fig. 2, lanes 11 to 15) .
Twenty-two serum specimens from patients with HCL caused by L. donovani infantum (group III) and 15 serum specimens from patients with HCL caused by L. tropica (group IV) were also tested. None of them recognized the Gp63 or the 32-kDa antigen of the L. donovani infantum membranes. A faint reactivity was found with low-molecular-mass antigens (less than 20 kDa) (Fig. 2, lanes 16 to 22) .
Control sera from healthy children and patients with diseases other than leishmaniasis (groups VI and VII, respec- (Fig. 3) 14) .
tivities (lanes 5 and 6). Interestingly, sera from six children with asymptomatic leishmanial infection were also unreactive with the P32 antigen (lane 7). However, significant reactivities were obtained with sera from patients with Chagas' disease (lane 8).
The MOD was 0.577 ± 0.083 (mean + standard error) for sera from patients with MVL and 0.105 ± 0.005 for sera from healthy controls. The cutoff value for reactivity with the P32 antigen, defined as the MOD + 2SDs of the value for the control group (group VI), was 0.161. This cutoff value allowed us to estimate the sensitivity and specificity of the ELISA with the electroeluted P32 antigen. A specificity of 94.3% and a sensitivity of 94.3% were obtained.
When ELISA was performed with SLA ( Fig. 4B ) the MOD for each group was higher (cutoff OD = 0.344). A significant reactivity was observed with some sera from patients with HCL caused by L. major (lane 2). This cross-reactivity was even more prominent when MBA was used as the antigen (Fig. 4C ) and extended to some of the sera from patients with HCL caused by L. infantum (lane 3) (cutoff OD = 0.349). The sensitivities of the tests with P32, SLA, and MBA antigens were 94.3, 71, and 83.5%, respectively, whereas the specificities under the same conditions were found to be 94.3, 91.4, and 88.5%, respectively.
When the cutoff value of the ELISA was defined as the MOD + 2SD obtained with sera from patients with clinical conditions other than MVL (groups II to VII), the specificities of the ELISAs with SLA or MBA decreased from 91.4 to 80.6% and 88.5 to 65.9%, respectively, while the specificities of the ELISA with purified P32 antigen were still high (90.3%), as were the values of the accuracy of positive prediction (73.4, 43.9, and 35.3%, respectively, for P32, SLA, and MBA). ELISA reactivities of sera from patients and healthy controls with purified P32 antigen (A), SLAs (B), or MBAs (C) extracted from L. donovani infantum promastigotes and revealed by sera from patients with MVL caused by L. donovani infantum (1), zoonotic cutaneous leishmaniasis caused by L. major (2), sporadic cutaneous leishmaniasis caused by L. donovani infantum (3), anthroponotic cutaneous leishmaniasis caused by L. tropica (4), healthy children (5), patients with diseases other than leishmaniasis (systemic lupus erythematosus, toxoplasmosis, hydatidosis, and tuberculosis) (6), seropositive children with asymptomatic L. donovani infantum infection (7), and South American patients with Chagas' disease caused by T. cruzii 6 (8) (numbers in parentheses indicate the numbers on the x axes in panels A to C). (7, 19, 27 (15, 28) . Additional studies on the P32 antibody responses in the murine model of experimental leishmaniasis are in progress in order to unravel these issues.
